Clinical Trials Logo

Osteonecrosis Due to Drugs, Jaw clinical trials

View clinical trials related to Osteonecrosis Due to Drugs, Jaw.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06457776 Recruiting - Clinical trials for Osteonecrosis Due to Drugs, Jaw

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

Start date: January 1, 2021
Phase:
Study type: Observational

The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.

NCT ID: NCT05664815 Recruiting - Clinical trials for Osteonecrosis Due to Drugs, Jaw

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

amniOST
Start date: September 22, 2023
Phase: Phase 2
Study type: Interventional

This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.